Spectrum appoints Dr Dalna Harvey as Regulatory Project Manager

HORSHAM, U.K. - April 7, 2014 - PRLog -- Dalna has a wealth of experience in regulatory affairs, working for companies such as Parexel, Chiron Corporation, Wyeth Pharmaceuticals, Pliva London and, most recently, Woodley BioReg. She will be responsible for updating Spectrum’s global healthcare clients on legislation amendments, providing strategic and technical advice and maintaining marketing authorisations.

“I am excited to join Spectrum and to develop its regulatory affairs service offering”, said Dalna Harvey.

Dr Angela Gisby, Managing Director of Spectrum, added “We are pleased to welcome Dalna to Spectrum and we look forward to the expert contribution she will bring to the business, particularly in the area ofregulatory intelligence”.

About Spectrum

Spectrum Regulatory Solutions was established in 2005 and provides a full-service consultancy to the healthcare industry. Uniquely, this comprises a suite of services which support manufacturers both during the run-up to obtaining marketing approval, and in post-marketing activities. These services include regulatory affairs, medical writing, safety and vigilance, market access, readability, quality assurance and compliance. Spectrum’s experience covers both medicinal products – pharmaceutical, biological, OTC, cosmetics, herbal and nutritional – and medical devices.